9th Advanced Forum on Biotech Patents

Thomas Saunders and John Serio, partners in the Boston office, will be presenting Freedom to Operate Assessments in Biotechnology: Analysis, Opinions and More at the upcoming American Conference Institute seminar.

The presentation will cover:

• Knowing when a freedom to operate analysis is necessary
• Guaranteeing the right to commercialize the IP at issue without infringing the claims of a third party
• • identifying and analyzing potential blocking patents
  • monitoring activity in pending third party applications
  • assessing infringement risks in biotech
  • considering indirect infringement issues
  • including un-issued patents and predated priority dates, common with biotechnology
  • evaluating patent issues outside the U.S.
• Accounting for the complexity of increasingly overlapping patents
• • determining claim scope
  • finding out what is pending
  • checking on ongoing prosecution to predict what may issue
• Effectively conducting the more elaborate search necessary for biologic compounds
• • defining and refining the topic
  • finding and mining useful tools and sources of information
  • managing the intricacies of sequence searching
• Deciding if an FTO opinion is necessary
• • evaluating the strength of a possible opinion
  • understanding the complexities of privilege and discovery issues relative to opinions
• Analyzing current case law that can affect your FTO analysis
• • the impact of the 271(e)(1) safe harbor

For more information, or to register, please visit the event's website.